| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.18 | 0.5 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.17 | 0.005 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.16 | 0.008 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.15 | 0.2 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.15 | 0.3 |